Yonatan Vainer

Yonatan Vainer serves as Chief Technology Officer at Empyrean Medical Systems, Inc.. Empyrean Medical Systems, Inc. operates in the research sector with approximately 33.0 employees.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • Our database includes 201,468 c suite-level executives.

Outlook Microsoft Office 365 Apache WordPress.org Google Analytics Google Tag Manager Shutterstock Mobile Friendly Google Font API YouTube reCAPTCHA IoT Remote Flutter Android AI Proofpoint

biotechnology research cancer treatment oncology research devices clinical devices therapeutics informatics radiation oncology particle physics ai in healthcare molecular biology chemistry machine learning precision oncology dose delivery radiation therapy medical devices fda approval patient outcomes real-time imaging workflow optimization safety in radiation small animal research user-friendly interface therapeutic compounds targeting accuracy self-shielding technology record-keeping advanced dosimetry predictive analytics clinical workflows biotechnology innovation disruptive technology patient safety research irradiators high-energy irradiator dosimetry systems treatment planning external beam therapy advanced cancer solutions collaborative research research collaboration novel oncology products biomedical engineering computational analytics continuous monitoring data science in oncology scientific breakthroughs hospital & health care artificial intelligence information technology & services enterprise software enterprises computer software b2b

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Yonatan Vainer in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Empyrean Medical Systems, Inc..

Yonatan Vainer's Position in the MessageCEO Database

• •Yonatan Vainer is 1 of 1 verified executive contact we track at Empyrean Medical Systems, Inc..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •36 verified contacts work at research companies in the 33.0 employee range (same size as Empyrean Medical Systems, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Yonatan Vainer directly?

Yonatan Vainer's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Empyrean Medical Systems, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Yonatan Vainer work for?

Yonatan Vainer is Chief Technology Officer at Empyrean Medical Systems, Inc., a company in the research sector with 33.0 employees.

Can I pitch or sell to Yonatan Vainer?

As Chief Technology Officer at Empyrean Medical Systems, Inc., Yonatan Vainer is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Yonatan Vainer directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Yonatan Vainer in?

Yonatan Vainer works in the research industry as Chief Technology Officer at Empyrean Medical Systems, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Yonatan Vainer's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Yonatan Vainer's profile is kept up-to-date with the latest available information.

Last updated: July 26, 2026